Risk governance
This article was originally published in The Gray Sheet
Executive Summary
Spurred by high-profile events like the European BSE crisis, Eucomed is planning to use its risk management paper as a lobbying tool in coming years. Prepared in response to the European Commission's 1"Communication from the Commission on the Precautionary Principle" and 2"European Governance - A White Paper", the association's "Risk Governance as applied to Medical Technology Products" will target policymakers who desire "zero risk, something which rarely exists," Eucomed says. Eucomed expects the paper, currently in development, to provide an overview of the risk management approach applied by industry. The European device trade group has completed scientific evaluation of the paper but is still conducting a political analysis...
You may also be interested in...
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.